文献速递流行病学与生物统计真实世界研究与卫生经济

重症监护登记中乳酸缺失:心源性休克多重插补框架

Missing lactate values in critical care registries: a multiple imputation framework for cardiogenic shock research.
PubMed 文献 · J Clin Epidemiol · 2026-07-22

该研究利用Critical Care Cardiology Trials Network登记中2017至2021年35个心脏重症监护病房的17,993例入院数据,刻画乳酸缺失机制并构建多重插补模型。缺失与患者严重程度相关,插补后乳酸用于IABP-SHOCK II风险评分导致显著风险重分类。结构化插补框架可减轻选择与测量偏倚,提高真实世界证据可靠性。

要点

  • 乳酸缺失非完全随机,与患者严重程度相关。
  • 结构化多重插补模型可减轻缺失导致的偏倚。
  • 插补乳酸用于IABP-SHOCK II评分致风险重分类。

核心结论

  • 乳酸缺失是重症监护登记中选择与测量偏倚的来源,结构化插补框架可减轻偏倚并提高心血管流行病学真实世界证据的可靠性。

研究设计与样本

  • 研究使用Critical Care Cardiology Trials Network登记中2017至2021年35个心脏重症监护病房的17,993例入院数据,刻画乳酸缺失机制并构建多重插补模型。

主要发现

  • 缺失与患者严重程度相关,确认数据非完全随机缺失。
  • 将插补乳酸纳入IABP-SHOCK II风险评分导致显著风险重分类,事件特异性净重分类在不同休克人群范围为-0.13%至2.70%。

临床怎么用

  • 在重症监护登记研究中,对乳酸缺失应采用结构化多重插补框架而非指示变量或直接排除,以提高风险评分的分析有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Lactate is a critical prognostic biomarker in observational studies of cardiac intensive care. In research settings, lactate is an integral component of prognostic models such as the IABP-SHOCK II risk score. However, lactate measurements are frequently missing due to heterogeneous clinical and logistical factors, potentially introducing systematic bias and compromising the validity of epidemiological inferences. In practice, missing lactate values are often replaced by indicator variables or excluded entirely, potentially hampering the analytical validity of research results. We illustrate a methodological framework to address missing lactate values in clinical research settings. STUDY DESIGN AND SETTING: We used data from 17,993 admissions recorded between 2017 and 2021 across 35 cardiac intensive care units participating in the Critical Care Cardiology Trials Network registry to characterize the mechanism of lactate missingness and develop a structured model for multiple imputation (MI). To assess the practical implications of this imputation procedure, we evaluated risk reclassification when using imputed lactate for computing the IABP-SHOCK II risk score. RESULTS: Missingness was associated with patient severity, confirming that the data were not missing completely at random. Identified predictors of lactate missingness were included in the MI model. The inclusion of imputed lactate in the IABP-SHOCK II risk score resulted in significant reclassification of risk, demonstrating the magnitude of bias inherent in naïve imputation (event-specific net reclassification ranging from -0.13% to 2.70% across shock populations). CONCLUSION: Missing lactate measurements are a source of selection and measurement bias in critical care registries. A structured imputation framework mitigates bias and improves the reliability of real-world evidence in cardiovascular epidemiology. PLAIN LANGUAGE SUMMARY: Lactate is a blood marker that helps clinicians assess how sick a patient is and is commonly used in risk prediction tools for patients with cardiogenic shock (CS). However, lactate measurements are often missing in clinical registries because testing practices vary across hospitals and patient groups. When lactate values are missing, researchers often either exclude those patients from analyses or assume that the missing value is low. Both approaches can introduce bias and may lead to inaccurate estimates of patient risk. In this study, we developed and evaluated a structured approach for handling missing lactate values using MI, a statistical method that estimates likely values based on other available clinical information. Using data from the Critical Care Cardiology Trials Network registry, we assessed how accounting for missing lactate affected risk classification in patients with CS. We found that replacing missing lactate values using a principled imputation approach led to meaningful changes in risk classification and identified additional patients at higher risk of death who would not have been recognized using standard approaches. The results were robust across multiple sensitivity analyses. These findings suggest that appropriate handling of missing biomarker data can improve the validity of registry-based research and may lead to more accurate assessment of patient risk when complete data are unavailable.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Thiesmeier R, Park JG, Patel SM, et al. Missing lactate values in critical care registries: a multiple imputation framework for cardiogenic shock research. J Clin Epidemiol. 2026. PMID: 42486195. doi:10.1016/j.jclinepi.2026.112426

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。